In situ vaccination and gene-mediated PD-L1 blockade for enhanced tumor immunotherapy

Recent progress in tumor photodynamic immunotherapy

(2020) Lijun Shen et al.   CHINESE CHEMICAL LETTERS

Synergistic tumor immunological strategy by combining tumor nanovaccine with gene-mediated extracellular matrix scavenger

(2020) Yingying Hu et al.   BIOMATERIALS

Delivery technologies for cancer immunotherapy

(2019) Rachel S. Riley et al.   NATURE REVIEWS DRUG DISCOVERY

Nanovaccine based on a protein-delivering dendrimer for effective antigen cross-presentation and cancer immunotherapy

(2019) Jun Xu et al.   BIOMATERIALS

Surgical Tumor-Derived Personalized Photothermal Vaccine Formulation for Cancer Immunotherapy

(2019) Xinyu Ye et al.   ACS Nano

Anti-Tumor Activity of Mannose-CpG-Oligodeoxynucleotides-Conjugated and Hepatoma Lysate-Loaded Nanoliposomes for Targeting Dendritic Cells In Vivo

(2019) Xiaomei Yang et al.   Journal of Biomedical Nanotechnology

Lyophilizable and Multifaceted Toll-like Receptor 7/8 Agonist-Loaded Nanoemulsion for the Reprogramming of Tumor Microenvironments and Enhanced Cancer Immunotherapy

(2019) Sun-Young Kim et al.   ACS Nano

Non-covalent glycosylated gold nanoparticles/peptides nanovaccine as potential cancer vaccines

(2019) Liming Zeng et al.   CHINESE CHEMICAL LETTERS

Neutralizing tumor-promoting inflammation with polypeptide-dexamethasone conjugate for microenvironment modulation and colorectal cancer therapy

(2019) Sheng Ma et al.   BIOMATERIALS

Recent progress of fully synthetic carbohydrate-based vaccine using TLR agonist as build-in adjuvant

(2018) Zhifang Zhou et al.   CHINESE CHEMICAL LETTERS

Functionalized Multi-Walled Carbon Nanotubes for Targeting Delivery of Immunostimulatory CpG Oligonucleotides Against Prostate Cancer

(2018) Qingming Xia et al.   Journal of Biomedical Nanotechnology

Recent advances in applying nanotechnologies for cancer immunotherapy

(2018) Reza Mahjub et al.   JOURNAL OF CONTROLLED RELEASE

Multiwalled Carbon Nanotubes Prevent Tumor Metastasis Through Switching M2-Polarized Macrophages to M1 via TLR4 Activation

(2018) Lianlian Wu et al.   Journal of Biomedical Nanotechnology

Real-Time Imaging Tracking of a Dual Fluorescent Vaccine Delivery System Based on Ovalbumin Loaded Zinc Phthalocyanine-Incorporated Copolymer Nanoparticles

(2018) Chang Wei et al.   Journal of Biomedical Nanotechnology

Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer

(2017) Ugur Sahin et al.   NATURE

An immunogenic personal neoantigen vaccine for patients with melanoma

(2017) Patrick A. Ott et al.   NATURE

Inflammation-Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti-PD1 Antibody

(2016) Chao Wang et al.   ADVANCED MATERIALS

Ultrasensitive pH Triggered Charge/Size Dual-Rebound Gene Delivery System

(2016) Xiuwen Guan et al.   NANO LETTERS

Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses

(2016) Kelly D Moynihan et al.   NATURE MEDICINE

Combination cancer immunotherapy and new immunomodulatory targets

(2015) Kathleen M. Mahoney et al.   NATURE REVIEWS DRUG DISCOVERY

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

The future of immune checkpoint therapy

(2015) P. Sharma et al.   SCIENCE

Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy

(2014) J. M. Taube et al.   CLINICAL CANCER RESEARCH

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

(2014) Matthew M. Gubin et al.   NATURE

Oncology Meets Immunology: The Cancer-Immunity Cycle

(2013) Daniel S. Chen et al.   IMMUNITY

Depleting tumor-specific Tregs at a single site eradicates disseminated tumors

(2013) Aurélien Marabelle et al.   JOURNAL OF CLINICAL INVESTIGATION

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

(2012) Julie R. Brahmer et al.   NEW ENGLAND JOURNAL OF MEDICINE

PD-1 and Its Ligands in Tolerance and Immunity

(2008) Mary E. Keir et al.   Annual Review of Immunology